# 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

> clinical trial · VERIFIED · 2026-06-16

Status: RECRUITING · Sponsor: Fred Hutchinson Cancer Center · Condition: Acute Lymphoblastic Leukemia in Remission

- Company: Fred Hutchinson Cancer Center
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT03670966

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.